BTL, the manufacturer behind the game-changing EMSCULPT technology, is continuing to raise the bar in aesthetics and non-invasive body shaping. Today, the brand announced its latest FDA clearance for EMSCULPT, which is now FDA cleared to strengthen, firm and tone the arms and calves with the newly unveiled Small Contour Applicators. Building upon the existing clearances for the abdomen, buttocks, and thighs, the new Small Contour Applicator brings the unrivaled EMSCULPT results to even more key muscle groups, making it the ONLY non-invasive treatment that is FDA cleared to tone and strengthen the arms and calves as well.
Multispecialty stem-cell task force recommends facility accreditation and licensure of clinics performing any type of stem-cell treatment
NEW YORK, March 12, 2019 /PRNewswire/ – A recent article published in the Aesthetic Surgery Journal, the clinical, peer-reviewed journal of the American Society for Aesthetic Plastic Surgery (ASAPS/The Aesthetic Society) is calling for the FDA to expedite its oversight of companies and clinics offering stem-cell products and therapies.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), the world's largest association of facial plastic surgeons, released its annual survey results for 2018. The annual survey explores the top trends in facial plastic surgery today.
The U.S. aesthetic neurotoxin marketplace is set to expand somewhat dramatically in 2019.
In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
The FDA recently approved the hyaluronic acid dermal filler Restylane Lyft to correct age-related volume loss on backs of the hands.